Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the third-leading cause of cancer-related death worldwide. 1 At our tertiary center, all patients with HCC are reviewed by a ...

Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

BioStem Technologies, Inc., a developer of placental-derived products for wound care, recently announced that patient ...

Basis Medical announced the completion of the first-in-human clinical procedures using the company’s Seclusion catheter to t ...

The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of new, evidence-based clinical ...

Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG ...

The FDA regulates medical devices under the Medical Devices Amendment of 1976, which now extends to > 8,000 manufacturers producing an estimated 190,000 distinct medical devices. 1,2 Spending on ...

StentIt, a Netherlands-based developer of stents with regenerative properties, announced the successful implantation of its resorb ...